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Abstract: A novel selective and substrate-dependent synthetic protocol has been developed
towards the synthesis of various fluorine-containing, highly functionalized cycloalkane derivatives.
The method involves the stereoselective epoxidation of some unsaturated cyclic β-amino acid
derivatives as model compounds, followed by a regioselective fluoride opening of oxiranes under
various conditions with Deoxofluor and XtalFluor-E reagents, thereby offering an insight into this
new epoxide opening methodology with fluoride.
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1. Introduction
Olefin epoxidation and the ring opening of epoxides with various nucleophiles is a widely used
method for the creation of different functional groups on the skeleton of organic molecules [1–7].
Because of the increasing importance of fluorinated biomolecules, the introduction of one or
more fluorine atoms into an organic molecule has received great interest in recent years. Besides the
important fluorine-containing drugs [8,9], several fluorinated α- and acyclic β-amino acids are known
as enzyme inhibitors, antitumoral agents, and antibiotics [10–13].
Taking into consideration the significance of fluorine in the structure of an organic molecule,
an oxirane ring opening with fluoride is a substantially useful approach for the incorporation of a
fluorine atom into a certain molecule [14–17]. However, the stereo- and regioselectivity in highly
functionalized cyclic scaffolds is a major challenge, which is associated with this type of transformation.
Various synthetic methods including asymmetric approaches for the oxirane ring opening with fluoride,
using fluorine-containing reagents such as pyridine·HF [18,19], Et3N·3HF [20,21], BF3·OEt2 [22,23],
HBF4·OEt2 or HBF4 [24,25], KHF2 [26], TBAF/KHF2, TBAF·3H2O/KF [27], KHF2/18-crown-6/chiral
Jacobsen chromium complex [28,29], AgHF2 with Ru catalyst [30], benzoyl fluoride, base,
and HFIP [31,32], have been reported. However, despite the relatively large number of synthetic
opportunities listed here, these molecular entities possessing the bicyclic oxirane fused ring system are
still considered complicated substrates for ring openings with fluoride. Consequently, there might be a
need for the development of novel synthetic techniques in view of this transformation.
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2. Results and Discussion
Our goal has been the development of a novel synthetic approach for the introduction of a fluorine
atom into the skeleton of a highly functionalized cycloalkane framework. We designed here a two-step
protocol: first, selective epoxidation; second, a selective oxirane ring opening with appropriately
selected fluoride reagents.
As a consequence of their important biological potential, highly functionalized amino acid
derivatives play a significant role in medicinal and organic chemistry. Some functionalized alicyclic
amino acid derivatives, such as oryzoxymycin, oseltamivir, peramivir, and icofungipen, exert relevant
bioactive properties [33].
There are relatively few methods in the literature [5,10–13] for the access of fluorine-containing,
highly functionalized β-amino acid derivatives. Therefore, the synthetic protocol for the access of
various fluorine-containing functionalized scaffolds regarding these valuable bioactive derivatives
was investigated here for the first time. The synthetic concept involves the stereoselective epoxidation
of some unsaturated β-amino esters (derived from bicyclic β-lactams) as selected model compounds.
In the next step, the regioselective fluoride opening of the formed oxiranes with both Deoxofluor and
XtalFluor-E reagents is carried out for the creation of novel, potentially bioactive, fluorine-containing
β-amino acid derivatives or heterocyclic systems.
First, the fluorination procedures were investigated with cyclopentane β-amino acid derivatives.
For this reason, a number of experiments were performed with systematic variation in the fluorinating
agent, the number of equivalents, the solvent, the temperature, the reaction time, and the usage of
additives. The all-cis epoxy amino ester (±)-2 (derived from bicyclic lactam (±)-1 according to our
earlier protocol) [34–36] was treated with XtalFluor-E [37] in dioxane at reflux (see Method D in the
Materials and Methods section). The opening of the oxirane ring yielded an oxazolidine derivative
(±)-5 as the sole product through intramolecular nucleophilic cyclization by the amide O-atom
(Scheme 1). It is noteworthy that the same reaction, when carried out in other common solvents such
as PhMe, CH2Cl2, and THF, yielded no transformation; only starting epoxide could be detected after
a day of reflux. Unfortunately, compound (±)-5, when reacted with Deoxofluor [38] under various
conditions (in different solvents at room temperature, reflux, etc.), did not yield the corresponding
fluorinated derivative. Next, the fluorination regent was changed from XtalFluor-E to Deoxofluor.
When epoxide (±)-2 was reacted with 6 equiv. of Deoxofluor in toluene (after some evaluation of
various solvents such as THF, 1,4-dioxane, and CH2Cl2, this proved to be the most efficient) in the
presence of one drop of EtOH at 20 ◦C for three days (see Method A in the Materials and Methods
section), two products were isolated: One was an unsaturated fluorinated derivative (±)-3 as a result
of the elimination and rearrangement (see also Scheme 2). The other product was an amino ester (±)-4
containing both fluorine and a hydroxyl group (Scheme 1). Derivatives (±)-3 and (±)-4 formed in a
2.3:1 ratio were separated and isolated by means of column chromatography. Although compound
(±)-2, depending on the reagent, yielded different types of products, by reacting either with XtalFluor
or Deoxofluor, the reactions with these reagents (analogously to the hydroxy–fluorine exchange;
see [37] and references therein) most likely took place with different mechanisms. The exact elucidation
of these mechanisms needs deeper evaluation, which is in progress in our laboratory.
The oxirane ring opening with both XtalFluor-E and Deoxofluor was studied in various solvents
(e.g., THF, CH2Cl2, dioxane, and PhMe) and in the presence of certain additives activating the oxiranes.
After some experimental investigations using different electrophilic additives (e.g., BF3·OEt2, NH4Cl,
AlCl3, and Li salts), the ring opening of oxirane (±)-2 was achieved with 4 equiv. of Deoxofluor in the
presence of TiCl4 (see Method C in the Material and Methods section), furnishing compound (±)-4 as
the only product, albeit in a modest yield (26%) (Scheme 1). It is noteworthy that, in all fluorination
transformations, alongside with the desired fluorine-containing products, either a significant amount
of starting epoxide or a polymeric material could be detected.
Similar studies have been carried out with “trans” epoxy amino ester (±)-6 (synthetized analogously
as reported earlier [34–36]), in which the ester and the carbamate groups are in a relative trans
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arrangement. In the reaction with XtalFluor-E (reflux in dioxane), epoxy amino ester (±)-6 provided a
cyclized derivative (±)-8 (see Method D in the Materials and Methods section). Deoxofluor, again,
yielded two products in a 1.7:1 ratio. One is unsaturated amino ester (±)-3, the same product
formed from all-cis amino esters (±)-2 (Scheme 1), while the second is a difluorinated derivative (±)-7
(see Method B in the Materials and Methods section) (Scheme 3).
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accomplished with 2 equiv. of Deoxofluor (CH2Cl2 and reflux), difluorinated derivative (±)-11 was
obtained. Note that a similar product could not be detected in the transformation of cyclopentane
derivative (±)-2. The yield of fluorinated amino ester (±)-11 might be slightly increased (76%) by
the addition of TiCl4 (Method C). Furthermore, the reaction of compound (±)-10 with XtalFluor-E
afforded oxazine derivative (±)-12, formed via the intramolecular ring closing (Method D) (Scheme 4).
Molecules 2016, 21, 1493 4 of 9 
 
Furtherm re, the reaction of compound (±)-10 with XtalFluor-E afforded oxazine derivative (±)-12, 
formed via the intramolecular ring closing (Method D) (Scheme 4). 
 
Scheme 4. Oxirane opening of cyclohexane all-cis epoxy amino ester (±)-10 with Deoxofluor and 
XtalFluor-E. 
However, rather surprisingly, the result of the fluorination of “trans” epoxy amino ester isomer 
(±)-13 (for similar epoxidation see also reference [39,40]) is different from that of the all-cis isomer (±)-10. 
The reaction of (±)-13 with Deoxofluor resulted in difluorinated amino ester (±)-15 and fluoroalcohol 
derivative (±)-16 formed in low yields (Method B). Next, the fluorination of (±)-13 accomplished with 
XtalFluor-E (reflux in dioxane) furnished oxazine derivative (±)-14, as a single product, in a modest 
yield (Method D) (Scheme 5). It is noteworthy, however, that, contrary to epoxide (±)-2, fluorination 
of (±)-10 in the presence of TiCl4 yielded no identifiable product. 
 
Scheme 5. Oxirane opening of cyclohexane “trans” amino ester (±)-13 with Deoxofluor and XtalFluor-E. 
3. Materials and Methods 
Epoxidations of cycloalkene β-amino esters were performed according to procedures published 
previously [34,39]. The 1H-NMR and 13C-NMR spectra of all new compounds are available in the 
Supplementary Materials. 
Experimental Procedures for the Oxirane Ring Openings 
Method A: To a solution of epoxide (0.5–0.7 mmol) in anhydrous toluene (10 mL) under an Ar 
atmosphere, one drop of anhydrous EtOH and 50% Deoxofluor in toluene (4 equiv.) were added, and the 
solution was stirred at 20 °C for the time given in the schemes. The solution was then diluted with CH2Cl2 
(30 mL), and the organic layer was washed with a saturated aqueous NaHCO3 solution (2 × 20 mL), 
dried (Na2SO4), and concentrated. The crude product was purified by column chromatography on silica 
gel (n-hexane/EtOAc). 
Method B: To a solution of epoxide (0.5 mmol) in anhydrous CH2Cl2 (10 mL) under an Ar 
atmosphere, one drop of anhydrous EtOH and 50% Deoxofluor in toluene (1 equiv.) were added, and 
the solution was kept at reflux temperature for 2 days. Then, 50% Deoxofluor in toluene (1 equiv.) 
was added again, and the solution was treated as above for one more day. The solution was then 
Scheme 4. Oxirane opening of cyclohexane all-cis epoxy amino ester (±)-10 with Deoxofluor
and XtalFluor-E.
However, rather surprisingly, the result of the fluorination of “trans” epoxy amino ester isomer
(±)-13 (for similar epoxidation see also reference [39,40]) is different from that of the all-cis isomer
(±)-10. The reaction of (±)-13 with Deoxofluor resulted in difluorinated amino ester (±)-15 and
fluoroalcohol derivative (±)-16 formed in low yields (Method B). Next, the fluorination of (±)-13
accomplished with XtalFluor-E (reflux in dioxane) furnished oxazine derivative (±)-14, as a single
product, in a modest yield (Method D) (Scheme 5). It is noteworthy, however, that, contrary to epoxide
(±)-2, fluorination of (±)-10 in the presence of TiCl4 yielded no identifiable product.
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3. Materials and Methods
Epoxidations of cycloalkene β-amino esters were performed according to procedures published
previously [34,39]. The 1H-NMR and 13C-NMR spectra of all new compounds are available in the
Supplementary Materials.
Experimental Procedures for the Oxirane Ring Openings
Method A: To a solution of epoxide (0.5–0.7 mmol) in anhydrous toluene (10 mL) under an Ar
atmosphere, one drop of anhydrous EtOH and 50% Deoxofluor in toluene (4 equiv.) were added,
and the solution was stirred at 20 ◦C for the time given in the schemes. The solution was then
diluted with CH2Cl2 (30 mL), and the organic layer was washed with a saturated aqueous NaHCO3
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solution (2 × 20 mL), dried (Na2SO4), and concentrated. The crude product was purified by column
chromatography on silica gel (n-hexane/EtOAc).
Method B: To a solution of epoxide (0.5 mmol) in anhydrous CH2Cl2 (10 mL) under an Ar
atmosphere, one drop of anhydrous EtOH and 50% Deoxofluor in toluene (1 equiv.) were added,
and the solution was kept at reflux temperature for 2 days. Then, 50% Deoxofluor in toluene (1 equiv.)
was added again, and the solution was treated as above for one more day. The solution was then
diluted with CH2Cl2 (30 mL), and the organic layer was washed with saturated aqueous NaHCO3
solution (2 × 20 mL), dried (Na2SO4), and concentrated. The crude product was purified by column
chromatography on silica gel (n-hexane/EtOAc).
Method C: To a solution of epoxide (0.5–0.75 mmol) in anhydrous toluene (10 mL) under an
Ar atmosphere, 50% Deoxofluor in toluene (4 equiv.) and the given amount of TiCl4 was added,
and the solution was stirred at 20 ◦C for the time given in the schemes. The solution was then
diluted with CH2Cl2 (30 mL), the organic layer was washed with a saturated aqueous NaHCO3
solution (2 × 20 mL), dried (Na2SO4), and concentrated. The crude product was purified by column
chromatography on silica gel (n-hexane/EtOAc).
Method D: To a solution of epoxide (0.5 mmol) in anhydrous 1,4-dioxane (10 mL) under an Ar
atmosphere, one drop of anhydrous EtOH (or without the addition of EtOH, see the schemes) was
added, followed by XtalFluor-E (1 equiv.). The reaction mixture was kept at a reflux temperature
for the time given in the schemes. The solution after cooling was diluted with CH2Cl2 (30 mL),
and the organic layer was washed with a saturated aqueous NaHCO3 solution (2 × 20 mL),
dried (Na2SO4), and concentrated. The crude product was purified by column chromatography
on silica gel (n-hexane/EtOAc).
Ethyl (1R*,2R*,3R*,5S*) 2-benzamido-6-oxabicyclo[3.1.0]hexane-3-carboxylate (±)-2. White solid; yield
97%; Rf = 0.48 (n-hexane/EtOAc 1:2); m.p. 85–88 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.27
(t, J = 7.12 Hz, 3H, CH3), 2.01–2.10 (m, 1H, CH2), 2.75–2.83 (m, 2H, CH2 and H-3), 3.49–3.53 (m, 1H,
H-1), 3.67–3.71 (m, 1H, H-5), 4.10–4.26 (m, 2H, OCH2), 4.89–4.96 (m, 1H, H-2), 7.42–7.55 (m, 3H, Ar-H),
7.85–7.91 (m, 2H, Ar-H), 8.63–8.79 (brs, 1H, N-H). 13C-NMR (100 MHz, CDCl3, TMS) δ = 14.4, 30.8,
37.5, 53.3, 54.0, 57.5, 61.6, 127.5, 129.0, 132.0, 134.4, 167.6, 174.8. MS (ESI, pos) m/z 298 (M + Na). Anal.
Calcd. for C15H17NO4: C, 65.44; H, 6.22; N, 5.09. Found: C, 65.11; H, 5.88; N, 4.81.
Ethyl (1R*,2R*,3S*,5S*) 2-benzamido-6-oxabicyclo[3.1.0]hexane-3-carboxylate (±)-6. White solid; yield
97%; Rf = 0.62 (n-hexane/EtOAc 1:2); m.p. 108–111 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.20
(t, J = 7.14 Hz, 3H, CH3), 2.10–2.21 (m, 2H, CH2), 2.40–2.52 (m, 1H, H-3), 3.56–3.62 (m, 1H, H-1),
3.69–3.76 (m, 1H, H-5), 4.07–4.22 (m, 2H, OCH2), 4.83–4.92 (m, 1H, H-2), 6.34 (d, J = 7.64 Hz, 1H, N-H),
7.41–7.48 (m, 2H, Ar-H), 7.49–7.55 (m, 1H, Ar-H), 7.76–7.82 (m, 2H, Ar-H). 13C-NMR (100 MHz, CDCl3,
TMS) δ = 14.5, 30.7, 44.0, 55.3, 55.5, 58.1, 61.6, 127.4, 129.0, 132.1, 134.5, 167.9, 173.3. MS (ESI, pos) m/z
276 (M + 1). Anal. Calcd. for C15H17NO4: C, 65.44; H, 6.22; N, 5.09. Found: C, 65.10; H, 6.86; N, 4.80.
Ethyl (1S*,3R*,4S*,6R*) 4-benzamido-7-oxabicyclo[4.1.0]heptane-3-carboxylate (±)-10. White solid; yield
69%; Rf = 0.47 (n-hexane/EtOAc 1:2); m.p. 100–109 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.31
(t, J = 7.12 Hz, 3H, CH3), 2.16–2.26 (m, 1H, CH2), 2.27–2.34 (m, 2H, CH2), 2.57–2.65 (m, 1H, CH2),
2.70–2.79 (m, 1H, H-3), 3.26–3.32 (m, 2H, H-1 and H-6), 4.12–4.27 (m, 2H, OCH2), 4.60–4.69 (m, 1H,
H-4), 7.34 (d, J = 9.20 Hz, 1H, N–H), 7.41–7.48 (m, 2H, Ar-H), 7.48–7.55 (m, 1H, Ar-H), 7.75–7.82 (m,
2H, Ar-H). 13C-NMR (100 MHz, CDCl3, TMS) δ = 14.5, 25.1, 29.1, 40.6, 44.5, 51.5, 52.1, 61.4, 127.4, 128.9,
131.8, 134.9, 166.8, 173.4. MS (ESI, pos) m/z 290 (M + 1). Anal. Calcd. for C16H19NO4: C, 66.42; H, 6.62;
N, 4.84. Found: C, 66.09; H, 6.29; N, 4.50.
Ethyl (1S*,3S*,4S*,6R*) 4-benzamido-7-oxabicyclo[4.1.0]heptane-3-carboxylate (±)-13. White solid; yield
91%; Rf = 0.48 (n-hexane/EtOAc 1:2); m.p. 108–119 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.30
(t, J = 7.14 Hz, 3H, CH3), 2.06–2.14 (m, 1H, CH2), 2.22–2.30 (m, 1H, CH2), 2.32–2.40 (m, 1H, CH2),
2.45–2.54 (m, 1H, CH2), 2.86–2.96 (m, 1H, H-3), 3.31–3.36 (m, 1H, H-6), 3.38–3.43 (m, 1H, H-1), 4.22
Molecules 2016, 21, 1493 6 of 10
(q, J = 7.06 Hz, 2H, OCH2), 4.61–4.70 (m, 1H, H-4), 7.04 (d, J = 9.44 Hz, 1H, N-H), 7.44–7.50 (m, 2H,
Ar-H), 7.51–7.57 (m, 1H, Ar-H), 7.77–7.84 (m, 2H, Ar-H). 13C-NMR (100 MHz, CDCl3, TMS) δ = 14.6,
23.7, 28.2, 40.9, 45.3, 51.8, 52.6, 61.5, 127.3, 129.0, 132.0, 134.6, 166.7, 173.4. MS (ESI, pos) m/z 290 (M + 1).
Anal. Calcd. for C16H19NO4: C, 66.42; H, 6.62; N, 4.84. Found: C, 66.11; H, 6.90; N, 4.49.
Ethyl 2-benzamido-4-fluorocyclopent-1-enecarboxylate (±)-3. Yellowish solid; yield 37%; Rf = 0.52
(n-hexane/EtOAc 5:1); m.p. 72–82 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.34 (t, J = 7.12 Hz,
3H, CH3), 2.82–2.85 (m, 1H, H-5), 2.90–2.94 (m, 1H, H-5), 3.46–3.81 (m, 2H, H-3), 4.22–4.32 (m, 2H,
OCH2), 5.20–5.39 (m, 1 H, H-4), 7.47–7.53 (m, 2H, Ar-H), 7.54–7.60 (m, 1H, Ar-H), 7.92–7.98 (m, 2H,
Ar-H), 11.26–11.36 (s, 1H, N-H). 19F-NMR (376 MHz, CDCl3) δ = −168.91. 13C-NMR (100 MHz, CDCl3,
TMS) δ = 14.8, 30.1, 37.05 and 37.29 (2J = 24.00 Hz), 42.69 and 42.94 (2J = 25.25 Hz), 60.7, 90.28 and 92.03
(1J = 176.35 Hz), 105.7, 128.0, 129.3, 132.9, 133.7, 151.9, 165.2. MS (ESI, pos) m/z 577 (2M + Na). Anal.
Calcd. for C15H16FNO3: C, 64.97; H, 5.82; N, 5.05. Found: C, 64.66; H, 5.48; N, 4.77.
Ethyl (1R*,2R*,3R*,4R*) 2-benzamido-4-fluoro-3-hydroxycyclopentane-carboxylate (±)-4. Yellow solid; yield
26%; Rf = 0.62 (n-hexane/EtOAc 1:1); m.p. 96–104 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.13
(t, J = 7.14 Hz, 3H, CH3), 2.19–2.36 (m, 1H, CH2), 2.46–2.65 (m, 1H, CH2), 3.58 (dt, J = 5.41 Hz and
8.91 Hz, 1H, H-1), 4.09 (q, J = 7.13 Hz, 2H, OCH2), 4.26 (dd, J = 4.78 Hz and 10.22 Hz, 1H, H-3),
4.84–4.92 (m, 1H, H-2), 4.95–5.12 (m, 1H, H-4), 7.05 (d, J = 7.36 Hz, 1H, N-H), 7.39–7.46 (m, 2H, Ar-H),
7.47–7.54 (m, 1H, Ar-H), 7.73–7.79 (m, 2H, Ar-H). 19F-NMR (376 MHz, CDCl3) δ = −175.66. 13C-NMR
(100 MHz, CDCl3, TMS) δ = 14.4, 34.25 and 34.49 (2J = 23.65 Hz), 44.78, 53.51, 62.36, 76.63 and 76.91
(2J = 27.70 Hz), 96.10 and 97.88 (1J = 179.42 Hz), 127.4, 129.1, 132.3, 177.4. MS (ESI, pos) m/z 296 (M + 1).
Anal. Calcd. for C15H18FNO4: C, 61.01; H, 6.14; N, 4.74. Found: C, 60.70; H, 5.79; N, 4.38.
Ethyl (3aR*,4R*,6S*,6aR*)-6-hydroxy-2-phenyl-4,5,6,6a-tetrahydro-3aH-cyclo-penta[d]oxazole-4-carboxylate
(±)-5. White solid; yield 57%; Rf = 0.35 (n-hexane/EtOAc 1:2); m.p. 130–134 ◦C. 1H-NMR (400 MHz,
d6-DMSO, TMS) δ = 1.23 (t, J = 7.08 Hz, 3H, CH3), 1.51–1.63 (m, 1H, CH2), 1.73–1.87 (m, 1H, CH2),
2.97–3.06 (m, 1H, H-4), 4.00–4.16 (m, 3H, OCH2 and H-3a), 4.74–4.84 (m, 2H, H-6 and H-6a), 5.05
(d, J = 7.12 Hz, 1H, O-H), 7.45–7.51 (m, 2H, Ar-H), 7.53–7.59 (m, 1H, Ar-H), 7.83–7.88 (m, 2H, Ar-H).
13C-NMR (100 MHz, CDCl3, TMS) δ = 14.7, 31.9, 46.3, 61.2, 71.8, 74.2, 83.2, 127.1, 128.8, 129.0, 132.2,
165.0, 171.0. MS (ESI, pos) m/z 276 (M + 1). Anal. Calcd. for C15H17NO4: C, 65.44; H, 6.22; N, 5.09.
Found: C, 65.08; H, 5.87; N, 4.73.
Ethyl (1S*,2R*,3S*,4R*) 2-benzamido-3,4-difluorocyclopentanecarboxylate (±)-7. White solid; yield 15%;
Rf = 0.39 (n-hexane/EtOAc 2:1); m.p. 152–161 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.26
(t, J = 7.12 Hz, 3H, CH3), 2.31–2.46 (m, 1H, CH2), 2.48–2.65 (m, 1H, CH2), 3.40–3.49 (m, 1H, H-1),
4.19 (q, J = 7.06 Hz, 2H, OCH2), 4.33–4.47 (m, 1H, H-2), 5.07–5.26 (m, 1H, H-4), 5.40–5.63 (m, 1H, H-3),
6.70 (d, J = 5.92 Hz, 1H, N-H), 7.42–7.48 (m, 2H, Ar-H), 7.50–7.56 (m, 1H, Ar-H), 7.73–7.78 (m, 2H,
Ar-H). 19F-NMR (376 MHz, CDCl3) δ = −196.34, −203.13. 13C-NMR (100 MHz, CDCl3, TMS) δ = 14.6,
31.01 and 31.22 (2J = 21.04 Hz), 41.83 and 41.89 (3J = 6.13 Hz), 57.96 and 58.20 (2J = 24.37 Hz), 61.81,
89.52 and 89.68 and 91.36 and 91.52 (1J = 185.10 Hz, 2J = 15.14 Hz), 91.91 and 92.06 and 93.84 and 94.00
(1J = 194.95 Hz, 2J = 15.62 Hz), 127.3, 129.1, 132.4, 134.2, 168.5, 173.6. MS (ESI, pos) m/z 298 (M + 1).
Anal. Calcd. for C15H17F2NO3: C, 60.60; H, 5.76; N, 4.71. Found: C, 60.25; H, 5.39; N, 4.40.
Ethyl (3aR*,4S*,6S*,6aR*)-6-hydroxy-2-phenyl-4,5,6,6a-tetrahydro-3aH-cyclo-penta[d]oxazole-4-carboxylate
(±)-8. White solid; yield 85%; Rf = 0.57 (n-hexane/EtOAc 1:2); m.p. 54–64 ◦C. 1H-NMR (400 MHz,
CDCl3, TMS) δ = 1.29 (t, J = 7.14 Hz, 3H, CH3), 1.74–1.84 (m, 1H, CH2), 2.18–2.26 (m, 1H, CH2),
3.09–3.16 (m, 1H, H-4), 4.19 (q, J = 7.14 Hz, 2H, OCH2), 4.42–4.50 (m, 1H, H-6), 4.93–5.00 (m, 1H, H-3a),
5.01–5.08 (m, 1H, H-6a), 7.41–7.48 (m, 2H, Ar-H), 7.49–7.58 (m, 1H, Ar-H), 7.99–8.06 (m, 2H, Ar-H).
13C-NMR (100 MHz, CDCl3, TMS) δ = 14.6, 34.0, 48.5, 61.5, 61.6, 73.1, 73.8, 83.6, 127.0, 127.5, 128.9,
132.4, 164.7, 174.1. MS (ESI, pos) m/z 276 (M + 1). Anal. Calcd. for C15H17NO4: C, 65.44; H, 6.22; N,
5.09. Found: C, 65.07; H, 5.85; N, 4.74.
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Ethyl (1R*,2S*,4S*,5R*) 2-benzamido-4,5-difluorocyclohexanecarboxylate (±)-11. White solid; yield 76%;
Rf = 0.44 (n-hexane/EtOAc 2:1); m.p. 158–162 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.31
(t, J = 7.14 Hz, 3H, CH3), 2.17–2.48 (m, 4H, CH2), 3.16–3.24 (m, 1H, H-1), 4.17–4.30 (m, 2H, OCH2),
4.61–4.86 (m, 2H, H-5 and H-2), 4.88–5.09 (m, 1H, H-4), 6.99 (d, J = 6.68 Hz, 1H, N-H), 7.42–7.49 (m,
2H, Ar-H), 7.50–7.57 (m, 1H, Ar-H), 7.74–7.80 (m, 2H, Ar-H). 19F-NMR (376 MHz, CDCl3) δ = −192.2,
−201.8. 13C-NMR (100 MHz, CDCl3, TMS) δ = 14.5, 27.48 and 27.70 (2J = 22.10 Hz), 31.99 and 32.19
(2J = 20.16 Hz), 42.0, 44.2, 61.8, 86.83 and 87.01 and 88.64 and 88.82 (1J = 182.07 Hz, 2J = 18.31 Hz), 87.2
and 87.42 and 89.03 and 89.21 (1J = 179.59 Hz, 2J = 17.45 Hz), 127.3, 129.0, 132.1, 134.6, 167.1, 173.7. MS:
(ESI, pos) m/z = 312 (M +1). Anal. Calcd. for C16H19F2NO3: C, 61.73; H, 6.15; N, 4.50. Found: C, 61.40;
H, 5.79; N, 4.16.
Ethyl (1R*,5S*,6R*,8S*) 8-hydroxy-3-phenyl-2-oxa-4-azabicyclo[3.3.1]non-3-ene-6-carboxylate (±)-12. Yellow
oil; yield 37%; Rf = 0.49 (n-hexane/EtOAc 1:3). 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.34 (t, J = 7.12 Hz,
3H, CH3), 1.58–1.71 (m, 1H, CH2), 1.78–1.85 (m, 1H, CH2), 2.15–2.27 (m, 2H, CH2), 2.75–2.83 (m, 1H,
H-6), 3.80–3.87 (m, 1H, H-8), 4.27 (q, J = 7.10 Hz, 2H, OCH2), 4.34–4.38 (m, 1H, H-5), 4.70–4.74 (m, 1H,
H-1), 7.37–7.43 (m, 2H, Ar-H), 7.43–7.50 (m, 1H, Ar-H), 7.93–7.97 (m, 2H, Ar-H). 13C-NMR (100 MHz,
CDCl3, TMS) δ = 14.6, 27.1, 28.3, 30.1, 47.2, 48.2, 61.3, 73.3, 74.8, 127.7, 128.4, 131.1, 131.8, 133.5, 157.9,
172.3. MS (ESI, pos) m/z 290 (M + 1). Anal. Calcd. for C16H19NO4: C, 66.42; H, 6.62; N, 4.84. Found: C,
66.09; H, 6.92; N, 4.50.
Ethyl (1S*,2S*,4S*,5R*) 2-benzamido-4,5-difluorocyclohexanecarboxylate (±)-15. Yellowish brown solid;
yield 10%; Rf = 0.53 (n-hexane/EtOAc 2:1); m.p. 42–51 ◦C. 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.16
(t, J = 7.12 Hz, 3H, CH3), 1.83–2.14 (m, 1H, CH2) 2.15–2.38 (m, 1H, CH2) or 1.83–2.38 (m, 1H, CH2),
2.42–2.58 (m, 1H, CH2), 2.80–2.95 (m, 1H, H-1), 4.05–4.20 (m, 2H, OCH2), 4.43–4.57 (m, 1H, H-2),
4.75–4.97 (m, 2H, H-4 and H-5), 6.31 (d, J = 7.56 Hz, 1H, N-H), 7.36–7.45 (m, 2H, Ar-H), 7.46–7.53 (m,
1H, Ar-H), 7.69–7.78 (m, 2H, Ar-H). 19F-NMR (376 MHz, CDCl3) δ = −192.71. 13C-NMR (100 MHz,
CDCl3, TMS) δ = 14.5, 28.66 and 28.86 (2J = 19.67 Hz), 32.67 and 32.87 (2J = 20.27 Hz), 43.4, 46.0, 61.7,
84.78 and 85.08 and 86.47 and 86.78 (1J = 170.33 Hz, 2J = 30.58 Hz), 85.95 and 86.29 and 87.69 and 88.03
(1J = 175.08 Hz, 2J = 34.96 Hz), 127.3, 129.0, 132.0, 134.7, 167.3, 172.9. MS (ESI, pos) m/z 312 (M + 1).
Anal. Calcd. for C16H19F2NO3: C, 61.73; H, 6.15; N, 4.50. Found: C, 61.39; H, 5.81; N, 4.87.
Ethyl (1R*,5S*,6S*,8S*) 8-hydroxy-3-phenyl-2-oxa-4-azabicyclo[3.3.1]non-3-ene-6-carboxylate (±)-14. Yellow
oil; yield 46%; Rf = 0.47 (n-hexane/EtOAc 2:3); 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.29 (t, J = 7.14 Hz,
3H, CH3), 1.39–1.50 (m, 1H, CH2), 1.84–1.91 (m, 1H, CH2), 1.98–2.06 (m, 1H, CH2), 2.30–2.38 (m, 1H,
CH2), 3.09–3.15 (m, 1H, H-6), 4.05–4.12 (m, 1H, H-8), 4.15–4.24 (m, 3H, OCH2 and H-5), 4.67–4.73
(m, 1H, H-1), 7.35–7.42 (m, 2H, Ar-H), 7.42–7.47 (m, 1H, Ar-H), 7.92–7.98 (m, 2H, Ar-H). 13C-NMR
(100 MHz, CDCl3, TMS) δ =14.6, 24.5, 27.9, 45.8, 47.6, 61.4, 70.6, 75.4, 127.6, 128.5, 131.3, 133.5, 158.4,
173.3. MS (ESI, pos) m/z 290 (M + 1). Anal. Calcd. for C16H19NO4: C, 66.42; H, 6.62; N, 4.84. Found: C,
66.07; H, 6.29; N, 4.51.
Ethyl (1S*,2S*,4S*,5S*) 2-benzamido-4-fluoro-5-hydroxycyclohexanecarboxylate (±)-16. Brown oil; yield 13%;
Rf = 0.53 (n-hexane/EtOAc 1:2). 1H-NMR (400 MHz, CDCl3, TMS) δ = 1.16 (t, J = 7.10 Hz, 3H, CH3),
1.91–2.40 (m, 4H, CH2), 2.97–3.07 (m, 1H, H-1), 4.03–4.16 (m, 3H, OCH2 and H-5), 4.45–4.56 (m, 1H,
H-2), 4.62–4.81 (m, 1H, H-4), 6.47 (d, J = 7.96 Hz, 1H, N-H), 7.34–7.43 (m, 2H, Ar-H), 7.43–7.51 (m, 1H,
Ar-H), 7.68–7.76 (m, 2H, Ar-H). 19F-NMR (376 MHz, CDCl3) δ = −187.14. 13C-NMR (100 MHz, CDCl3,
TMS) δ = 14.5, 30.5, 32.11 and 32.31 (2J = 20.31 Hz), 43.2, 46.6, 61.5, 65.94 and 66.21 (2J = 27.35 Hz), 89.60
and 91.32 (1J = 172.66 Hz), 127.3, 128.9, 131.9, 134.8, 167.5, 173.9. MS (ESI, pos) m/z 310 (M + 1). Anal.
Calcd. for C16H20FNO4: C, 62.12; H, 6.52; N, 4.53. Found: C, 61.81; H, 6.21; N, 4.17.
4. Conclusions
A novel synthetic procedure has been developed for the access of some highly functionalized
fluorine-containing alicyclic scaffolds. The synthetic procedure was based on the ring opening reaction
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of functionalized cycloalkane-fused oxiranes with both XtalFluor-E and Deoxofluor as fluoride sources.
Through an investigation with various experimental conditions, the opening of the three-membered
heterocyclic ring with fluoride was found to be highly substrate-dependent. However, this substrate
directable synthetic investigation of an epoxide opening with fluoride using XtalFluor-E or Deoxofluor
needs further study in order to achieve higher yields. Synthetic investigations using other highly
functionalized model compounds under various experimental conditions are currently being studied
in our laboratory.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/21/
11/1493/s1.
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